HRP980206B1 - Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors - Google Patents

Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors

Info

Publication number
HRP980206B1
HRP980206B1 HR980206A HRP980206A HRP980206B1 HR P980206 B1 HRP980206 B1 HR P980206B1 HR 980206 A HR980206 A HR 980206A HR P980206 A HRP980206 A HR P980206A HR P980206 B1 HRP980206 B1 HR P980206B1
Authority
HR
Croatia
Prior art keywords
aryl
making
cox
inhibitors
pyridines useful
Prior art date
Application number
HR980206A
Other languages
English (en)
Inventor
Pye J Philip
Ashok Maliakal
Kai Rossen
Ralph P Volante
Jess Sager
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9709686.1A external-priority patent/GB9709686D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of HRP980206A2 publication Critical patent/HRP980206A2/hr
Publication of HRP980206B1 publication Critical patent/HRP980206B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B43/00Formation or introduction of functional groups containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • C07D213/50Ketonic radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/52Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HR980206A 1997-04-18 1998-04-16 Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors HRP980206B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4564297P 1997-04-18 1997-04-18
GBGB9709686.1A GB9709686D0 (en) 1997-05-13 1997-05-13 Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors

Publications (2)

Publication Number Publication Date
HRP980206A2 HRP980206A2 (en) 1998-12-31
HRP980206B1 true HRP980206B1 (en) 2002-02-28

Family

ID=26311530

Family Applications (1)

Application Number Title Priority Date Filing Date
HR980206A HRP980206B1 (en) 1997-04-18 1998-04-16 Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors

Country Status (22)

Country Link
EP (1) EP0975596B1 (de)
JP (1) JP3300369B2 (de)
KR (1) KR20010006546A (de)
CN (1) CN1182117C (de)
AT (1) ATE270275T1 (de)
AU (1) AU729730B2 (de)
BR (1) BR9808923B1 (de)
CA (1) CA2287482C (de)
CZ (1) CZ293246B6 (de)
DE (1) DE69824839T2 (de)
EA (1) EA002190B1 (de)
ES (1) ES2223128T3 (de)
HK (1) HK1023771A1 (de)
HR (1) HRP980206B1 (de)
HU (1) HU226999B1 (de)
NZ (1) NZ500390A (de)
PL (1) PL190265B1 (de)
RS (1) RS49901B (de)
SK (1) SK285037B6 (de)
TW (1) TW492959B (de)
UA (1) UA66792C2 (de)
WO (1) WO1998047871A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE253559T1 (de) * 1999-01-14 2003-11-15 Lonza Ag Verfahren zur herstellung von 1-(6-methylpyridin- 3-yl)-2- 4-(methylsulfonyl phenyl)ethanon
MXPA01007169A (es) 1999-01-14 2003-06-06 Lonza Ag 1-(6-metilpiridin-3-il)-2-(4-(metilsulfonil)fenil)etanona y metodo para su elaboracion.
US6566527B1 (en) 1999-07-27 2003-05-20 Merck & Co., Inc. Process for preparing 1-(6-methylpyridin-3-yl)-2-[4-methylsulphonyl)-phenyl]ethanone
JP4773013B2 (ja) * 1999-07-27 2011-09-14 ロンザ アーゲー 1−(6−メチルピリジン−3−イル)−2−[4−(メチルスルホニル)フェニル]エタノンの製造方法
NZ519781A (en) 1999-12-23 2004-04-30 Nitromed Inc Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
JP2001261647A (ja) * 2000-03-22 2001-09-26 Sankio Chemical Co Ltd ピリジン誘導体の製造方法
DK1303265T3 (da) 2000-07-20 2007-11-12 Lauras As Anvendelse af COX-2-inhibitorer, som immunostimulerende midler ved behandling af HIV eller AIDS
EP2582690B1 (de) * 2010-06-16 2018-07-25 Glenmark Generics Limited Verfahren zur herstellung von 2,3-diaryl-5-substituierten pyridinen und deren zwischenstoffen
MY163379A (en) * 2010-11-15 2017-09-15 Virdev Intermediates Pvt Ltd A process for cyclooxygenase-2 selective inhibitor
CN103204803A (zh) 2012-01-13 2013-07-17 阿尔弗雷德·E·蒂芬巴赫尔有限责任两合公司 用于合成依托考昔的方法
WO2014114352A1 (en) * 2013-01-25 2014-07-31 Synthon Bv Process for making etoricoxib
WO2015036550A1 (en) 2013-09-13 2015-03-19 Synthon B.V. Process for making etoricoxib

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH561716A5 (de) * 1971-05-10 1975-05-15 Ciba Geigy Ag
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5686470A (en) * 1995-02-10 1997-11-11 Weier; Richard M. 2, 3-substituted pyridines for the treatment of inflammation
WO1996025405A1 (en) * 1995-02-13 1996-08-22 G.D. Searle & Co. Substituted isoxazoles for the treatment of inflammation
US5643933A (en) * 1995-06-02 1997-07-01 G. D. Searle & Co. Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
US5677318A (en) * 1996-07-11 1997-10-14 Merck Frosst Canada, Inc. Diphenyl-1,2-3-thiadiazoles as anti-inflammatory agents
HU227732B1 (en) * 1996-07-18 2012-01-30 Merck Frosst Canada Ltd Substituted pyridine derivatives as selective cyclooxigenase-2 inhibitors and use thereof

Also Published As

Publication number Publication date
JP2000513018A (ja) 2000-10-03
RS49901B (sr) 2008-08-07
SK143699A3 (en) 2000-07-11
CZ293246B6 (cs) 2004-03-17
EP0975596B1 (de) 2004-06-30
SK285037B6 (sk) 2006-05-04
EA002190B1 (ru) 2002-02-28
PL336298A1 (en) 2000-06-19
DE69824839T2 (de) 2005-07-07
TW492959B (en) 2002-07-01
HUP0003155A3 (en) 2002-01-28
DE69824839D1 (de) 2004-08-05
CA2287482A1 (en) 1998-10-29
HK1023771A1 (en) 2000-09-22
ES2223128T3 (es) 2005-02-16
AU729730B2 (en) 2001-02-08
EA199900948A1 (ru) 2000-04-24
JP3300369B2 (ja) 2002-07-08
WO1998047871A1 (en) 1998-10-29
BR9808923B1 (pt) 2010-08-24
BR9808923A (pt) 2000-08-01
NZ500390A (en) 2001-08-31
AU7257198A (en) 1998-11-13
CN1260782A (zh) 2000-07-19
CZ369099A3 (cs) 2000-04-12
EP0975596A1 (de) 2000-02-02
PL190265B1 (pl) 2005-11-30
HU226999B1 (en) 2010-04-28
YU53699A (sh) 2001-12-26
UA66792C2 (uk) 2004-06-15
HRP980206A2 (en) 1998-12-31
HUP0003155A2 (hu) 2001-06-28
CA2287482C (en) 2004-02-17
CN1182117C (zh) 2004-12-29
ATE270275T1 (de) 2004-07-15
KR20010006546A (ko) 2001-01-26

Similar Documents

Publication Publication Date Title
YU64100A (sh) Postupak za sintetizovanje cox-2 inhibitora
WO1999015503A3 (en) Process for making diaryl pyridines useful as cox-2 inhibitors
LU91145I9 (de)
ZA944501B (en) Phenyl heterocycles as cox-2 inhibitors
PT1206474E (pt) Compostos de sulfonilfenilpirazole uteis como inibidores de cox-2
ES2171723T3 (es) 3,4-diaril-2-hidroxi-2,5-dihidrofuranos como profarmacos de inhibidores de cox-2.
CA2258048A1 (en) Process of preparing phenyl heterocycles useful as cox-2 inhibitors
HRP980206B1 (en) Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors
ZA200404752B (en) 6-aminomorphinane derivatives method for the production and use thereof
ATE193526T1 (de) Alkylierte styrole als prodrugs zu cox-2- inhibitoren
DE69715173D1 (en) Bisarylcyclobutenderivate als cyclooxygenasehemmer
EE9800230A (et) Difenüülstilbeenid kui COX-2 inhibiitorite eelravimid
PL330227A1 (en) Method of obtaining phenylheterocyclic compounds suitable as cox-2 inhibitors

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
PNAN Change of the applicant name, address/residence

Owner name: MERCK SHARP & DOHME CORP., US

ODRP Renewal fee for the maintenance of a patent

Payment date: 20110329

Year of fee payment: 14

PBON Lapse due to non-payment of renewal fee

Effective date: 20120417